MFAP5 and gastric cancer: Across eight analyzed GC datasets, high-MFAP5 expressions were consistently linked to worse prognoses; patients with high-MFAP5 expressions displayed inferior clinical outcomes consistently across datasets (Figures 7F, G, respectively).